Myomo Net Debt To E B I T D A from 2010 to 2024

MYO Stock  USD 6.36  0.02  0.31%   
Myomo Net Debt To EBITDA yearly trend continues to be very stable with very little volatility. Net Debt To EBITDA is likely to drop to 0.42. Net Debt To EBITDA is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). View All Fundamentals
 
Net Debt To EBITDA  
First Reported
2010-12-31
Previous Quarter
0.77721767
Current Value
0.42
Quarterly Volatility
0.76095634
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Myomo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Myomo's main balance sheet or income statement drivers, such as Depreciation And Amortization of 543.6 K, Interest Expense of 172.4 K or Selling General Administrative of 10.4 M, as well as many indicators such as Price To Sales Ratio of 7.3, Dividend Yield of 0.0 or PTB Ratio of 17.26. Myomo financial statements analysis is a perfect complement when working with Myomo Valuation or Volatility modules.
  
Check out the analysis of Myomo Correlation against competitors.

Latest Myomo's Net Debt To E B I T D A Growth Pattern

Below is the plot of the Net Debt To E B I T D A of Myomo Inc over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Myomo's Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Myomo's overall financial position and show how it may be relating to other accounts over time.
Net Debt To E B I T D A10 Years Trend
Pretty Stable
   Net Debt To E B I T D A   
       Timeline  

Myomo Net Debt To E B I T D A Regression Statistics

Arithmetic Mean0.48
Geometric Mean0.56
Coefficient Of Variation158.74
Mean Deviation0.47
Median0.38
Standard Deviation0.76
Sample Variance0.58
Range3.4081
R-Value0.27
Mean Square Error0.58
R-Squared0.07
Significance0.34
Slope0.05
Total Sum of Squares8.11

Myomo Net Debt To E B I T D A History

2024 0.42
2023 0.78
2022 0.47
2021 1.49
2020 1.07
2019 0.17
2018 0.63

About Myomo Financial Statements

Myomo investors utilize fundamental indicators, such as Net Debt To E B I T D A, to predict how Myomo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Debt To EBITDA 0.78  0.42 

Pair Trading with Myomo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myomo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myomo will appreciate offsetting losses from the drop in the long position's value.

Moving together with Myomo Stock

  0.62EW Edwards Lifesciences CorpPairCorr
  0.94GH Guardant HealthPairCorr
  0.73LH LaboratoryPairCorr

Moving against Myomo Stock

  0.8DRIO DarioHealth CorpPairCorr
  0.72EDAP EDAP TMS SAPairCorr
  0.63VERO Venus ConceptPairCorr
  0.42CI Cigna CorpPairCorr
  0.35VTAK Catheter Precision Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Myomo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myomo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myomo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myomo Inc to buy it.
The correlation of Myomo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myomo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myomo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myomo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:
Check out the analysis of Myomo Correlation against competitors.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.23)
Revenue Per Share
0.835
Quarterly Revenue Growth
0.813
Return On Assets
(0.31)
Return On Equity
(0.83)
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.